146 related articles for article (PubMed ID: 35245098)
1. Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis.
Jatoi I
J Clin Oncol; 2022 May; 40(14):1595. PubMed ID: 35245098
[No Abstract] [Full Text] [Related]
2. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
Barratt A
BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
[No Abstract] [Full Text] [Related]
3. Epidemiology of Ductal Carcinoma In Situ.
Iatrakis G; Zervoudis S
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S15-S21. PubMed ID: 34967307
[TBL] [Abstract][Full Text] [Related]
4. The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography.
Welch HG; Woloshin S; Schwartz LM
J Natl Cancer Inst; 2008 Feb; 100(4):228-9. PubMed ID: 18270336
[No Abstract] [Full Text] [Related]
5. Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.
Heinävaara S; Sarkeala T; Anttila A
Br J Cancer; 2014 Sep; 111(7):1463-8. PubMed ID: 25121953
[TBL] [Abstract][Full Text] [Related]
6. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
7. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
[TBL] [Abstract][Full Text] [Related]
8. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
9. Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma.
Hui Y; Lu S; Wang H; Resnick MB; Wang Y
Histopathology; 2019 Jan; 74(2):358-362. PubMed ID: 30117181
[No Abstract] [Full Text] [Related]
10. [Breast neoplasms: histological classification].
Sakamoto G
Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
[No Abstract] [Full Text] [Related]
11. How to prevent invasive breast cancer: detect and excise duct carcinoma in situ.
Cady B
J Surg Oncol; 1998 Oct; 69(2):60-2. PubMed ID: 9808505
[No Abstract] [Full Text] [Related]
12. Overdiagnosis of breast cancer in Norway: what have the authors adjusted for?
Zahl PH; Suhrke P; Jørgensen KJ
Int J Cancer; 2013 Dec; 133(11):2754-5. PubMed ID: 23650050
[No Abstract] [Full Text] [Related]
13. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
14. Ductal Carcinoma In Situ in Pregnant Women.
Chiba A; Bunce EE
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S113-S119. PubMed ID: 34967319
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.
Lee J; Jung JH; Kim WW; Park CS; Lee RK; Kim HJ; Kim WH; Park HY
BMC Cancer; 2020 Sep; 20(1):934. PubMed ID: 32993586
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ in the male-to-female transgender population.
Stafford A; Shobieri A; Stamatakos M; Edmiston K
Breast J; 2020 Dec; 26(12):2439-2440. PubMed ID: 33274801
[No Abstract] [Full Text] [Related]
17. Mode of detection and secular time for ductal carcinoma in situ.
Pisano ED
J Natl Cancer Inst Monogr; 2010; 2010(41):142-4. PubMed ID: 20956819
[TBL] [Abstract][Full Text] [Related]
18. Breast screening overdiagnosis. Protocols are evidence based.
Dobson HM; Thomas JS
BMJ; 2009 Aug; 339():b3262. PubMed ID: 19671610
[No Abstract] [Full Text] [Related]
19. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.
Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C
Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening study hampered by inadequate data.
Tabár L
BMJ; 2014 Nov; 349():g6823. PubMed ID: 25424720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
